Results 11 to 20 of about 25,084 (169)

Haemophilus influenzae type b reemergence after combination immunization [PDF]

open access: yes, 2006
An increase in Haemophilus influenzae type b (Hib) in British children has been linked to the widespread use of a diphtheria/tetanus/acellular pertussis combination vaccine (DTaP-Hib).
Mary P.E. Slack   +23 more
core   +4 more sources

Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules

open access: yesBMC Infectious Diseases, 2021
Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 + 
Eva Hong   +6 more
doaj   +1 more source

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France

open access: yesnpj Vaccines, 2022
Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha   +2 more
doaj   +1 more source

Product review on the IMD serogroup B vaccine Bexsero®

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj   +1 more source

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease

open access: yesBMC Research Notes, 2020
Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
Muhamed-Kheir Taha, Ala-Eddine Deghmane
doaj   +1 more source

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

open access: yesFrontiers in Microbiology, 2023
BackgroundNon-typeable Haemophilus influenzae has become increasingly important as a causative agent of invasive diseases following vaccination against H. influenzae type b.
Esra Ekinci   +13 more
doaj   +1 more source

Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon

open access: yesInternational Journal of Infectious Diseases, 2020
Objectives: To identifyHaemophilus species and characterise the antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Serges Tchatchouang   +11 more
doaj   +1 more source

The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal. [PDF]

open access: yes, 2014
Haemophilus influenzae type b (Hib) is now recognized as an important pathogen in Asia. To evaluate disease susceptibility, and as a marker of Hib transmission before routine immunization was introduced in Kathmandu, 71 participants aged 7 months-77 ...
Neelam Adhikari   +44 more
core   +2 more sources

Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. [PDF]

open access: yes, 2007
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization services in Kenya in 2001. We aimed to estimate the cost-effectiveness of Hib vaccine delivery. METHODS: A model was developed to follow the Kenyan 2004 birth
Akumu, Angela Oloo   +8 more
core   +1 more source

Haemophilus influenzae Carriage among Healthy Children in Portugal, 2015–2019

open access: yesMicroorganisms, 2022
Haemophilus influenzae is an important cause of mucosal and invasive infections and a common colonizer of the upper respiratory tract. As there are no recent data on H.
Maria Paula Bajanca-Lavado   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy